Pre-earnings options volume in FibroGen (FGEN) is normal with calls leading puts 11:1. Implied volatility suggests the market is anticipating a move near 18.1%, or 0c, after results are released. Median move over the past eight quarters is 14.0%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FGEN:
- Options Volatility and Implied Earnings Moves Today, March 17, 2025
- Is FGEN a Buy, Before Earnings?
- FibroGen’s Strategic Sale and Pipeline Focus Justify Buy Rating Amid Financial Strength
- FibroGen China sale ‘shrewd strategic transaction,’ says H.C. Wainwright
- M&A News: AstraZeneca Expands China Footprint With FibroGen Deal